Log In
Print this Print this

DepoCyt, DepoCyte, cytarabine

  Manage Alerts
Collapse Summary General Information
Company Pacira Pharmaceuticals Inc.
DescriptionSustained release cytarabine using DepoFoam lipid-based delivery
Molecular Target DNA polymerase
Mechanism of ActionDNA synthesis inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationLymphoma
Indication DetailsTreat lymphomatous meningitis; Treat neoplastic meningitis; Treat neoplastic meningitis caused by cancer metastases
Regulatory Designation
PartnerMundipharma International Ltd.;
Sigma-Tau Group

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Get a free BioCentury trial today